{"title":"Intuitive Surgical vs Smith+Nephew: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/intuitive-surgical-vs-smith-nephew","comparison":"Intuitive Surgical ranks 1 on the Robotics 100 with a score of 100; Smith+Nephew ranks 65 with 81. Intuitive Surgical is ahead on deployment, production, commercials, progress, technology, positioning and leverage. Level on firepower. Intuitive Surgical is based in Sunnyvale, United States, Smith+Nephew in Watford, United Kingdom. Intuitive Surgical: Established. Smith+Nephew: Established. Intuitive Surgical is named in 12 signals and Smith+Nephew in 2.","companies":[{"name":"Intuitive Surgical","url":"https://www.frontiertechintelligence.com/companies/intuitive-surgical","city":"Sunnyvale","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Intuitive Surgical is the US surgical-robotics leader with an installed base of 11,710 da Vinci and 1,096 Ion systems (468 placed in Q2-26 alone) and 14M cumulative procedures. Q2-26 revenue was $2.89B (+19%, 85% recurring) with procedures up 16%, a fast da Vinci 5 ramp (246 placed), and H1 free cash flow of $1.8B (+71%), with guidance raised. It is the top-scored company on the list.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":1,"score":100,"tier":"member","scores":{"gate_ne":["firepower"],"leverage":10,"position":10,"progress":10,"firepower":10,"commercial":10,"deployment":10,"production":10,"technology":10},"why":"Intuitive Surgical develops and sells da Vinci robotic surgical systems, including the da Vinci 5 platform cleared for cardiac procedures. Its core business is medical and surgical robotics.","segment":"Medical & surgical","layer":"Systems"},"signals_total":12,"facts_total":12},{"name":"Smith+Nephew","url":"https://www.frontiertechintelligence.com/companies/smith-nephew","city":"Watford","country":"United Kingdom","stage":"Established","founded":null,"last_round":null,"positioning":"Smith+Nephew's CORI handheld robotic platform (within the LSE:SN group) covers revision knee, hip, and shoulder procedures in hospital and ASC settings, with CORI XT first clinical cases in June 2026 (shoulder arthroplasty at Duke Health, knee at NYU Langone). It showcased handheld robotics at AAOS 2026. CORI-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":65,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Smith+Nephew develops and sells the CORI Surgical System, a robotic-assisted platform for orthopedic surgery. Its medical robotics business qualifies as a medical and surgical robotics system.","segment":"Medical & surgical","layer":"Systems"},"signals_total":2,"facts_total":10}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}